PAA 4.44% 21.5¢ pharmaust limited

PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-15

  1. 8,827 Posts.
    lightbulb Created with Sketch. 1711
    Lets hope they have a clear pathway set out to the finish line, one that has how they intend to deal with the funding issue.
    I dont want to hear anything about funding from possible partnerships, canine licences etc.

    I want to hear what things they are going to do different to the old board and what they are going to put in place to ènsure as best as possible that stated time lines are met and responsibilities are taken for any actions stated.

    I want to hear when they now expect the phase 2 / 3 study to commence and when or if they intend to submit the required request to hold this study in the various countries they intend for the study to run in.

    Be nice to also be told how the first 9 patients on the extended study are progressing along with when the last 2 patients started on the trial.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
21.5¢
Change
-0.010(4.44%)
Mkt cap ! $95.68M
Open High Low Value Volume
22.0¢ 22.0¢ 21.3¢ $125.5K 578.7K

Buyers (Bids)

No. Vol. Price($)
6 144480 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 318615 3
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.